CompletedPhase 3NCT01215747
Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis
Studying AA amyloidosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- C.T. Development America, Inc.
- Principal Investigator
- Tomasz Sablinski, MD, PhDCT Development America, Inc.
- Intervention
- KIACTA (eprodisate disodium)(drug)
- Enrollment
- 261 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2010 – 2016
Study locations (30)
- Raffi Minasian MD a Medical Corporation, Glendale, California, United States
- Boston Medical Center, Boston, Massachusetts, United States
- Ohio State University Medical Center, Columbus, Ohio, United States
- UZ Leuven, Leuven, Belgium
- Al Hussain University Hospital, Cairo, Egypt
- Tartu University Hospital, Tartu, Estonia
- Helsingin yliopistollinen keskussairaala / Meilahti, Helsinki, Finland
- Hôpital Henri Mondor, Créteil, France
- Hôpital Claude Huriez, Lille, France
- Tbilisi Heart and Vascular Clinic Ltd, Tbilisi, Georgia
- Universität Heidelberg, Heidelberg, Germany
- Regency Hospital, Kanpur, India
- Muljibhai Patel Urological Hospital, Nadiād, India
- Sir Ganga Ram Hospital, New Delhi, India
- Bnei Zion Medical Center, Haifa, Israel
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01215747 on ClinicalTrials.govOther trials for AA amyloidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06974877Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNCT06354322Unclassified GENotypes of Autoinflammatory Diseases and AA AmyloidosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT04265040DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research StudiesUniversity Hospital Heidelberg
- ACTIVE NOT RECRUITINGNANCT03584022Clinical Trial to Assess the Safety of a Novel Scaffold BiomaterialMayo Clinic